All Stories

  1. NGF-mediated tumor–stroma crosstalk promotes prostate cancer aggressiveness
  2. Rewiring melanoma cell fate: TRPM8 modulators trigger apoptosis and boost NK cell cytotoxicity
  3. Correction: Androgens as the “old age stick” in skeletal muscle
  4. Androgens as the “old age stick” in skeletal muscle
  5. Role of the androgen receptor in melanoma aggressiveness
  6. Corrigendum: Estrogens modulate somatostatin receptors expression and synergize with the somatostatin analog pasireotide in prostate cells
  7. Filamin A in triple negative breast cancer
  8. Chromatin looping links gene expression to the assembly of transcription factories (Review)
  9. Filamin A cooperates with the androgen receptor in preventing skeletal muscle senescence
  10. Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance
  11. Role of the Androgen Receptor in Gender-Related Cancers
  12. The Androgen Regulation of Matrix Metalloproteases in Prostate Cancer and Its Related Tumor Microenvironment
  13. The Role of the Androgen Receptor in Skeletal Muscle and Its Utility as a Target for Restoring Muscle Functions
  14. The nerve growth factor-delivered signals in prostate cancer and its associated microenvironment: when the dialogue replaces the monologue
  15. The Nerve-Growth Factor Signaling in Gender-Related Cancers
  16. New Approaches Targeting the Invasive Phenotype of Prostate Cancer-Associated Fibroblasts
  17. Androgens and NGF Mediate the Neurite-Outgrowth through Inactivation of RhoA
  18. Modelling the growth of a PHB producer methanotrophic bacterial strain using a Computational Fluid Dynamic approach: Discontinuous methane feeding strategy
  19. Agri-Food By-Products in Cancer: New Targets and Strategies
  20. Poly(3-hydroxybutyrate) production from methane in bubble column bioreactors: Process simulation and design optimization
  21. Inhibition of Vps34 and p110δ PI3K Impairs Migration, Invasion and Three-Dimensional Spheroid Growth in Breast Cancer Cells
  22. New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models
  23. P-272 Estrogen receptors influence the epithelial-to-mesenchymal transition of pancreatic cancer cell lines
  24. Targeting ERβ to fight melanoma: a new valid approach?
  25. New Insights and Emerging Therapeutic Approaches in Prostate Cancer
  26. A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells
  27. Therapeutic potential of TRPM8 antagonists in prostate cancer
  28. Communication between cells: exosomes as a delivery system in prostate cancer
  29. ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities
  30. Exploiting the mechanism of estrogen-induced transcription to fight breast cancer
  31. Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells
  32. Correction to: The androgen receptor/filamin A complex as a target in prostate cancer microenvironment
  33. The androgen receptor/filamin A complex as a target in prostate cancer microenvironment
  34. Role of the demethylase LSD-1 in cell functions
  35. Acetylation/methylation at lysine 9 in histone H3 as a mark of nucleosome asymmetry in human somatic breast cells
  36. Role of ROS generated by nuclear protein modification in the development of cancer
  37. Breast cancer stem cells: the role of sex steroid receptors
  38. Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
  39. Nerve Growth Factor Induces Proliferation and Aggressiveness in Prostate Cancer Cells
  40. BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition
  41. NGF Induces Proliferation and Aggressiveness In Prostate Cancer Cells.
  42. Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly
  43. Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
  44. The Androgen Receptor in Breast Cancer
  45. The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia
  46. Cross-talk between androgen receptor and nerve growth factor receptor in prostate cancer cells: implications for a new therapeutic approach
  47. Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation
  48. Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury
  49. Extranuclear partners of androgen receptor: at the crossroads of proliferation, migration, and neuritogenesis
  50. Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer
  51. Faculty of 1000 evaluation for Progesterone receptor modulates ERα action in breast cancer.
  52. Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells
  53. Cross-talk between androgen receptor/filamin A and TrkA regulates neurite outgrowth in PC12 cells
  54. Role of JMJD6 in Breast Tumourigenesis
  55. Non-Genomic Androgen Action Regulates Proliferative/Migratory Signaling in Stromal Cells
  56. Faculty of 1000 evaluation for LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
  57. Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells
  58. Abstract 2108: Estrogen non genomic signalling is activated in tamoxifen-resistant breast cancer
  59. Nuclear receptor-induced transcription is driven by spatially and timely restricted waves of ROS
  60. Expression of Autophagy-Related Proteins According to Androgen Receptor and HER-2 Status in Estrogen Receptor-Negative Breast Cancer
  61. Extremely Low-Frequency Electromagnetic Fields Cause G1 Phase Arrest through the Activation of the ATM-Chk2-p21 Pathway
  62. Epigenetic drugs against cancer: an evolving landscape
  63. Phosphorylation of H3 serine 10 by IKKα governs cyclical production of ROS in estrogen-induced transcription and ensures DNA wholeness
  64. A Firmer Understanding of the Effect of Hypergravity on Thyroid Tissue: Cholesterol and Thyrotropin Receptor
  65. Diversin Is Overexpressed in Breast Cancer and Accelerates Cell Proliferation and Invasion
  66. The Deficiency of Tumor Suppressor Prep1 Accelerates the Onset of Meis1- Hoxa9 Leukemogenesis
  67. Dissection of Estrogen Receptor Alpha Signaling Pathways in Osteoblasts Using RNA-Sequencing
  68. Metformin Inhibits Androgen-Induced IGF-IR Up-Regulation in Prostate Cancer Cells by Disrupting Membrane-Initiated Androgen Signaling
  69. Analysis of Histone Posttranslational Modifications in the Control of Chromatin Plasticity Observed at Estrogen-Responsive Sites in Human Breast Cancer Cells
  70. Phosphoinositide 3-Kinase Assay in Breast Cancer Cell Extracts
  71. Resveratrol Couples Apoptosis with Autophagy in UVB-Irradiated HaCaT Cells
  72. Nuclear Ras2-GTP Controls Invasive Growth in Saccharomyces cerevisiae
  73. Protein-Tyrosine Phosphatase H1 Increases Breast Cancer Sensitivity to Antiestrogens by Dephosphorylating Estrogen Receptor at Tyr537
  74. RTK/ERK Pathway under Natural Selection Associated with Prostate Cancer
  75. Targeting Androgen Receptor/Src Complex Impairs the Aggressive Phenotype of Human Fibrosarcoma Cells
  76. Correction: TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
  77. Estradiol and Tamoxifen Induce Cell Migration through GPR30 and Activation of Focal Adhesion Kinase (FAK) in Endometrial Cancers with Low or without Nuclear Estrogen Receptor α (ERα)
  78. Differentially Expressed Androgen-Regulated Genes in Androgen-Sensitive Tissues Reveal Potential Biomarkers of Early Prostate Cancer
  79. Faculty of 1000 evaluation for FBXL2- and PTPL1-mediated degradation of p110-free p85β regulatory subunit controls the PI(3)K signalling cascade.
  80. Faculty of 1000 evaluation for Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins.
  81. Retinoic acid impairs estrogen signaling in breast cancer cells by interfering with activation of LSD1 via PKA
  82. Acetylcholine Acts on Androgen Receptor to Promote the Migration and Invasion but Inhibit the Apoptosis of Human Hepatocarcinoma
  83. Does Changing Androgen Receptor Status during Prostate Cancer Development Impact upon Cholesterol Homeostasis?
  84. Estradiol Receptor (ER) Chromatin Immunoprecipitation in MCF-7 Cells
  85. p130Cas Over-Expression Impairs Mammary Branching Morphogenesis in Response to Estrogen and EGF
  86. Faculty of 1000 evaluation for Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
  87. The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer
  88. A Switch Role of Src in the Biphasic EGF Signaling of ER-Negative Breast Cancer Cells
  89. Polyproline and Tat transduction peptides in the study of the rapid actions of steroid receptors
  90. Neuregulin Promotes Incomplete Autophagy of Prostate Cancer Cells That Is Independent of mTOR Pathway Inhibition
  91. Nuclear Factor-Kappa B Inhibition Can Enhance Apoptosis of Differentiated Thyroid Cancer Cells Induced by 131I
  92. ALK-Activating Homologous Mutations in LTK Induce Cellular Transformation
  93. Faculty of 1000 evaluation for Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib.
  94. Faculty of 1000 evaluation for Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.
  95. Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells
  96. Advances in Rapid Sex-Steroid Action
  97. Non-genomic Action of Steroid Hormones: More Questions than Answers
  98. Faculty of 1000 evaluation for Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5.
  99. Androgen-Induced Cell Migration: Role of Androgen Receptor/Filamin A Association
  100. Analysis of Androgen Receptor Rapid Actions in Cellular Signaling Pathways: Receptor/Src Association
  101. Targeting rapid action of sex steroid receptors in breast and prostate cancers
  102. Steroid signaling activation and intracellular localization of sex steroid receptors
  103. Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines
  104. Faculty of 1000 evaluation for c-Abl regulates estrogen receptor alpha transcription activity through its stabilization by phosphorylation.
  105. Cell proliferation regulated by estradiol receptor: Therapeutic implications
  106. Faculty of 1000 evaluation for miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
  107. Prostate cancer stem cells: the role of androgen and estrogen receptors
  108. Non-Genomic Action of Sex Steroid Hormones
  109. Signaling-dependent nuclear export of estradiol receptor controls cell cycle progression in breast cancer cells
  110. Faculty of 1000 evaluation for A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis.
  111. Faculty of 1000 evaluation for Tumours with PI3K activation are resistant to dietary restriction.
  112. Sex-steroid hormones and EGF signalling in breast and prostate cancer cells: Targeting the association of Src with steroid receptors
  113. Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells
  114. Integrating signals between cAMP and MAPK pathways in breast cancer
  115. Inhibition of Estradiol Receptor/Src Association and Cell Growth by an Estradiol Receptor   Tyrosine-Phosphorylated Peptide
  116. Src-dependent signalling pathway regulation by sex-steroid hormones: Therapeutic implications
  117. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth
  118. Crosstalk between EGFR and Extranuclear Steroid Receptors
  119. p85 regulatory subunit of PI3K mediates cAMP–PKA and estrogens biological effects on growth and survival
  120. Steroid Receptor Regulation of Epidermal Growth Factor Signaling through Src in Breast and Prostate Cancer Cells: Steroid Antagonist Action
  121. Role of Atypical Protein Kinase C in Estradiol-Triggered G1/S Progression of MCF-7 Cells
  122. Rapid signalling pathway activation by androgens in epithelial and stromal cells
  123. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action
  124. Two Domains of the Progesterone Receptor Interact with the Estrogen Receptor and Are Required for Progesterone Activation of the c-Src/Erk Pathway in Mammalian Cells
  125. Interactions of Estrogen Receptors with Signal Cascade Molecules
  126. Sex steroid hormones act as growth factors
  127. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells
  128. cAMP signaling selectively influences Ras effectors pathways
  129. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation
  130. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis
  131. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor
  132. Protein Tyrosine Phosphorylation and Estradiol Action
  133. A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers
  134. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
  135. Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells
  136. Properties of a purified estradiol-dependent calf uterus tyrosine kinase
  137. Phosphorylation and estradiol binding of estrogen receptor in hormone-dependent and hormone-independent GR mouse mammary tumors
  138. In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor
  139. Serine phosphorylation of biosynthetic pro-urokinase from human tumor cells
  140. Phosphorylation on Tyrosine ofin VitroSynthesized Human Estrogen Receptor Activates Its Hormone Binding
  141. Serine phosphorylation of biosynthetic prourokinase plasminogen activator in human cells
  142. In VitroInteraction of Estradiol Receptor with Ca2+-Calmodulin
  143. Oestradiol stimulates tyrosine phosphorylation and hormone binding activity of its own receptor in a cell-free system.
  144. [54] Calmodulin-stimulated estradiol receptor-tyrosine kinase I
  145. Phosphorylation on tyrosine of oestradiol-17β receptor in uterus and interaction of oestradiol-17β and glucocorticoid receptors with antiphosphotyrosine antibodies
  146. Estradiol receptor: phosphorylation on tyrosine in uterus and interaction with anti-phosphotyrosine antibody.
  147. Hormone regulation of 17β-estradiol receptor phosphorylation on tyrosine
  148. Activation-inactivation of hormone binding sites of the oestradiol-17β receptor is a multiregulated process
  149. Hypnosis for upper gastrointestinal endoscopy
  150. Calmodulin-stimulated phosphorylation of 17 beta-estradiol receptor on tyrosine.
  151. Direct evidence of in vitro phosphorylation-dephosphorylation of the estradiol-17β receptor. role of Ca2+-Calmodulin in the activation of hormone binding sites
  152. Phosphorylation-Dephosphorylation of the Estradiol Receptor Regulates its Hormone Binding Activity
  153. Phosphorylation of calf uterus 17β-estradiol receptor by endogenous Ca2+-stimulated kinase activating the hormone binding of the receptor
  154. Evidence that invivo estradiol receptor translocated into nuclei is dephosphorylated and released into cytoplasm
  155. Hormone binding of estradiol-17β receptor: Evidence for its regulation by cytoplasmic phosphorylation and nuclear dephosphorylation. Prevention of dephosphorylation by antiestrogens
  156. Dephosphorylation of oestradiol nuclear receptorin vitro. A hypothesis on the mechanism of action of non-steroidal anti-oestrogens
  157. ATP-dependent enzyme activating hormone binding of estradiol receptor
  158. Inactivation of oestrogen receptor in vitro by nuclear dephosphorylation
  159. In vitro inactivation of oestrogen receptor by nuclei
  160. PHOSPHORYLATION ON TYROSINE OF THE 173-ESTRADIOL RECEPTOR
  161. The Progesterone Receptor/Estradiol Receptor Association and the Progestin-Triggered S-Phase Entry